Edition:
United Kingdom

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

2.66USD
15 Dec 2017
Change (% chg)

$-0.08 (-2.92%)
Prev Close
$2.74
Open
$2.75
Day's High
$2.75
Day's Low
$2.62
Volume
766,345
Avg. Vol
232,888
52-wk High
$5.73
52-wk Low
$2.62

Chart for

About

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables... (more)

Overall

Beta: 1.91
Market Cap(Mil.): $564.09
Shares Outstanding(Mil.): 115.59
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-Pacific Biosciences of California files for mixed shelf of upto $150 mln

* Pacific Biosciences of California Inc files for mixed shelf of upto $150 million - SEC filing‍​ Source text: (http://bit.ly/2ulOr9C) Further company coverage:

02 Aug 2017

BRIEF-Pacific Biosciences Of California qtrly net loss per share $0.26

* Pacific Biosciences Of California Inc - total revenue for Q2 of 2017 was $20.1 million, compared to $20.7 million for Q2 of 2016

02 Aug 2017

BRIEF-Pacific Biosciences signs agreement with Novogene to purchase ten sequel systems

* Pacbio announces new agreement with Novogene to purchase ten sequel systems

02 Aug 2017

Competitors

  Price Chg
Illumina, Inc. (ILMN.OQ) $216.55 +5.70
Thermo Fisher Scientific Inc. (TMO.N) $192.27 +3.95

Earnings vs. Estimates